Modern detection of prostate cancer's bone metastasis: Is the bone scan era over?

Advances in Urology

Volumn , Issue , 2012, Pages

  Tombal, Bertrand ^a   Lecouvet, Frederic ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855163105     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2012/893193     Document Type: Review

References (68)

1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 International Journal of Cancer 2010 127 12 2893 2917
2. Verhagen P. C. M. S., Schröder F. H., Collette L., Bangma C. H., Does Local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review European Urology 2010 58 2 261 269
3. Rigaud J., Tiguert R., Le Normand L., Karam G., Glemain P., Buzelin J. M., Bouchot O., Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy Journal of Urology 2002 168 4 I 1423 1426 (Pubitemid 35034138)
4. Soloway M. S., Hardeman S. W., Hickey D., Raymond J., Todd B., Soloway S., Moinuddin M., Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan Cancer 1988 61 1 195 202 (Pubitemid 18023133)
5. Nørgaard M., Jensen A.Ø, Jacobsen J. B., Cetin K., Fryzek J. P., Srensen H. T., Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007) Journal of Urology 2010 184 1 162 167
6. Loberg R. D., Logothetis C. J., Keller E. T., Pienta K. J., Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype Journal of Clinical Oncology 2005 23 32 8232 8241 (Pubitemid 46211560)
7. Smith M. R., Cook R. J., Coleman R., Brown J., Lipton A., Major P., Hei Y. J., Saad F., Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer Urology 2007 70 2 315 319 (Pubitemid 47362256)
8. National Comprehensive Cancer Network, Clinical practice guidelines in oncology. Prostatecancer 2011 1
9. Heidenreich A., Bolla M., Joniau S., Guidelines on prostate cancer Urology EAo 2010 European Association of Urology
10. Scher H. I., Halabi S., Tannock I., Morris M., Sternberg C. N., Carducci M. A., Eisenberger M. A., Higano C., Bubley G. J., Dreicer R., Petrylak D., Kantoff P., Basch E., Kelly W. K., Figg W. D., Small E. J., Beer T. M., Wilding G., Martin A., Hussain M., Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group Journal of Clinical Oncology 2008 26 7 1148 1159
11. Therasse P., Measuring the clinical response. What does it mean? European Journal of Cancer 2002 38 14 1817 1823 (Pubitemid 35256090)
12. Therasse P., Arbuck S. G., Eisenhauer E. A., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Journal of the National Cancer Institute 2000 92 205 216
13. Aus G., Bergdahl S., Lodding P., Lilja H., Hugosson J., Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer-results from a prospective, population-based randomized controlled trial European Urology 2007 51 3 659 664 (Pubitemid 46110933)
14. Rana A., Karamanis K., Lucas M. G., Chisholm G. D., Identification of metastatic disease by T category Gleason score and serum PSA level in patients with carcinoma of the prostate British Journal of Urology 1992 69 3 277 281
15. Briganti A., Passoni N., Ferrari M., Capitanio U., Suardi N., Gallina A., Pozzo L. F. D., Picchio M., Di Girolamo V., Salonia A., Gianolli L., Messa C., Rigatti P., Montorsi F., When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool European Urology 2010 57 4 551 558
16. Thompson I., Thrasher J. B., Aus G., Burnett A. L., Canby-Hagino E. D., Cookson M. S., D'Amico A. V., Dmochowski R. R., Eton D. T., Forman J. D., Goldenberg S. L., Hernandez J., Higano C. S., Kraus S. R., Moul J. W., Tangen C. M., Guideline for the management of clinically localized prostate cancer: 2007 update Journal of Urology 2007 177 6 2106 2131 (Pubitemid 46726449)
17. Gomez P., Manoharan M., Kim S. S., Soloway M. S., Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU International 2004 94 3 299 302 (Pubitemid 39120167)
18. Pound C. R., Partin A. W., Eisenberger M. A., Chan D. W., Pearson J. D., Walsh P. C., Natural history of progression after PSA elevation following radical prostatectomy Journal of the American Medical Association 1999 281 17 1591 1597 (Pubitemid 29211767)
19. Choueiri T. K., Dreicer R., Paciorek A., Carroll P. R., Konety B., A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy Journal of Urology 2008 179 3 906 910
20. Smith M. R., Kabbinavar F., Saad F., Hussain A., Gittelman M. C., Bilhartz D. L., Wynne C., Murray R., Zinner N. R., Schulman C., Linnartz R., Zheng M., Goessl C., Hei Y. J., Small E. J., Cook R., Higano C. S., Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer Journal of Clinical Oncology 2005 23 13 2918 2925 (Pubitemid 46224110)
21. Smith M. R., Cook R., Lee K. -A., Nelson J. B., Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer Cancer 2011 117 10 2077 2085
22. Condon B. R., Buchanan R., Garvie N. W., Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging British Journal of Radiology 1981 54 637 18 23 (Pubitemid 11199188)
23. Pollen J. J., Gerber K., Ashburn W. L., Schmidt J. D., Nuclear bone imaging in metastatic cancer of the prostate Cancer 1981 47 11 2585 2594 (Pubitemid 11113722)
24. Einhorn T. A., Vigorita V. J., Aaron A., Localization of technetium-99m methylene diphosphonate in bone using microautoradiography Journal of Orthopaedic Research 1986 4 2 180 187 (Pubitemid 16025830)
25. Eustace S., Tello R., DeCarvalho V., Carey J., Wroblicka J. T., Melhem E. R., Yucel E. K., A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases American Journal of Roentgenology 1997 169 6 1655 1661 (Pubitemid 127469800)
26. Hamaoka T., Madewell J. E., Podoloff D. A., Hortobagyi G. N., Ueno N. T., Bone imaging in metastatic breast cancer Journal of Clinical Oncology 2004 22 14 2942 2953 (Pubitemid 41079914)
27. Rybak L. D., Rosenthal D. I., Radiological imaging for the diagnosis of bone metastases Quarterly Journal of Nuclear Medicine 2001 45 1 53 64 (Pubitemid 32586342)
28. Daldrup-Link H. E., Franzius C., Link T. M., Laukamp D., Sciuk J., Jrgens H., Schober O., Rummeny E. J., Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET American Journal of Roentgenology 2001 177 1 229 236 (Pubitemid 32578088)
29. Jacobson A. F., Fogelman I., Bone scanning in clinical oncology: does it have a future? European Journal of Nuclear Medicine 1998 25 9 1219 1223 (Pubitemid 28446045)
30. Schirrmeister H., Guhlmann A., Elsner K., Kotzerke J., Glatting G., Rentschler M., Neumaier B., Trger H., Nssle K., Reske S. N., Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET Journal of Nuclear Medicine 1999 40 10 1623 1629 (Pubitemid 29471151)
31. Gosfield E. III, Alavi A., Kneeland B., Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases Journal of Nuclear Medicine 1993 34 12 2191 2198 (Pubitemid 24002966)
32. McKillop J. H., McDougall I. R., The role of skeletal scanning in clinical oncology British Medical Journal 1980 281 6237 407 409 (Pubitemid 10093061)
33. Venkitaraman R., Sohaib A., Cook G., MRI or bone scan or both for staging of prostate cancer? Journal of Clinical Oncology 2007 25 36 5837 5838
34. Schirrmeister H., Glatting G., Hetzel J., Nssle K., Arslandemir C., Buck A. K., Dziuk K., Gabelmann A., Reske S. N., Hetzel M., Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer Journal of Nuclear Medicine 2001 42 12 1800 1804 (Pubitemid 34016348)
35. Han L. J., Au-Yong T. K., Tong W. C. M., Chu K. S., Szeto L. T., Wong C. P., Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain European Journal of Nuclear Medicine 1998 25 6 635 638 (Pubitemid 28297839)
36. Even-Sapir E., Metser U., Mishani E., Lievshitz G., Lerman H., Leibovitch I., The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F- Fluoride PET/CT Journal of Nuclear Medicine 2006 47 2 287 297 (Pubitemid 46780894)
37. Nozaki T., Yasuda K., Akashi T., Fuse H., Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer International Journal of Urology 2008 15 6 516 519 (Pubitemid 351713180)
38. Helyar V., Mohan H. K., Barwick T., Livieratos L., Gnanasegaran G., Clarke S. E. M., Fogelman I., The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate European Journal of Nuclear Medicine and Molecular Imaging 2010 37 4 706 713
39. Schirrmeister H., Guhlmann A., Kotzerke J., Santjohanser C., Kühn T., Kreienberg R., Messer P., Nssle K., Elsner K., Glatting G., Trger H., Neumaier B., Diederichs C., Reske S. N., Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography Journal of Clinical Oncology 1999 17 8 2381 2389 (Pubitemid 29368236)
40. Schirrmeister H., Khn T., Guhlmann A., Santjohanser C., Hrster T., Nssle K., Koretz K., Glatting G., Rieber A., Kreienberg R., Buck A. C., Reske S. N., Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures European Journal of Nuclear Medicine 2001 28 3 351 358
41. Uematsu T., Yuen S., Yukisawa S., Aramaki T., Morimoto N., Endo M., Furukawa H., Uchida Y., Watanabe J., Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer American Journal of Roentgenology 2005 184 4 1266 1273 (Pubitemid 43821911)
42. Ghanem N., Uhl M., Brink I., Schfer O., Kelly T., Moser E., Langer M., Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone European Journal of Radiology 2005 55 1 41 55 (Pubitemid 40798487)
43. Cook G. J. R., Fogelman I., The role of positron emission tomography in the management of bone metastases Cancer 2000 88 12 2927 2933 (Pubitemid 30413175)
44. Eschmann S. M., Pfannenberg A. C., Rieger A., Aschoff P., Mller M., Paulsen F., Anastasiadis A., Claussen C. D., Bares R., Schlemmer H. P., Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer NuklearMedizin 2007 46 5 161 168 (Pubitemid 47612279)
45. Kotzerke J., Volkmer B. G., Glatting G., Van den Hoff J., Gschwend J. E., Messer P., Reske S. N., Neumaier B., Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer NuklearMedizin 2003 42 1 25 30 (Pubitemid 36231688)
46. Yu E. Y., Muzi M., Hackenbracht J. A., Rezvani B. B., Link J. M., Montgomery R. B., Higano C. S., Eary J. F., Mankoff D. A., C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy Clinical Nuclear Medicine 2011 36 3 192 198
47. Beheshti M., Vali R., Waldenberger P., Fitz F., Nader M., Loidl W., Broinger G., Stoiber F., Foglman I., Langsteger W., Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study European Journal of Nuclear Medicine and Molecular Imaging 2008 35 10 1766 1774
48. Beheshti M., Vali R., Waldenberger P., Fitz F., Nader M., Hammer J., Loidl W., Pirich C., Fogelman I., Langsteger W., The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT Molecular Imaging and Biology 2010 12 1 98 107
49. Eschmann S. M., Pfannenberg A. C., Rieger A., Aschoff P., Mller M., Paulsen F., Anastasiadis A., Claussen C. D., Bares R., Schlemmer H. P., Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer NuklearMedizin 2007 46 5 161 168 (Pubitemid 47612279)
50. Groves A. M., Beadsmoore C. J., Cheow H. K., Balan K. K., Courtney H. M., Kaptoge S., Win T., Harish S., Bearcroft P. W. P., Dixon A. K., Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient European Radiology 2006 16 5 1066 1073
51. Daffner R. H., Lupetin A. R., Dash N., MRI in the detection of malignant infiltration of bone marrow American Journal of Roentgenology 1986 146 2 353 358 (Pubitemid 16143933)
52. Sanal S. M., Flickinger F. W., Caudell M. J., Sherry R. M., Detection of bone marrow involvement in breast cancer with magnetic resonance imaging Journal of Clinical Oncology 1994 12 7 1415 1421 (Pubitemid 24206240)
53. Traill Z. C., Talbot D., Golding S., Gleeson F. V., Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases Clinical Radiology 1999 54 7 448 451 (Pubitemid 29355976)
54. Frank J. A., Ling A., Patronas N. J., Carrasquillo J. A., Horvath K., Hickey A. M., Dwyer A. J., Detection of malignant bone tumors: MR imaging vs scintigraphy American Journal of Roentgenology 1990 155 5 1043 1048 (Pubitemid 20357006)
55. Haubold-Reuter B. G., Duewell S., Schilcher B. R., Marincek B., Schulthess G. K., The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study European Journal of Nuclear Medicine 1993 20 11 1063 1069 (Pubitemid 23353797)
56. Kattapuram S. V., Khurana J. S., Scott J. A., El-Khoury G. Y., Negative scintigraphy with positive magnetic resonance imaging in bone metastases Skeletal Radiology 1990 19 2 113 116 (Pubitemid 20057251)
57. Tombal B., Rezazadeh A., Therasse P., Van Cangh P. J., Vande Berg B., Lecouvet F. E., Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases Prostate 2005 65 2 178 187 (Pubitemid 41362285)
58. Vande Berg B. C., Lecouvet F. E., Michaux L., Ferrant A., Maldague B., Malghem J., Magnetic resonance imaging of the bone marrow in hematological malignancies European Radiology 1998 8 8 1335 1344 (Pubitemid 128662790)
59. Vande Berg B. C., Lecouvet F. E., Michaux L., Magnetic resonance imaging of the normal bone marrow Skeletal Radiology 1998 27 9 471 483 (Pubitemid 28468457)
60. Vanel D., Bittoun J., Tardivon A., MRI of bone metastases European Radiology 1998 8 8 1345 1351 (Pubitemid 128662791)
61. Turner J. W., Hawes D. R., Williams R. D., Magnetic resonance imaging for detection of prostate cancer metastatic to bone Journal of Urology 1993 149 6 1482 1484 (Pubitemid 23164550)
62. Walker R., Kessar P., Blanchard R., Dimasi M., Harper K., DeCarvalho V., Yucel E. K., Patriquin L., Eustace S., Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience Journal of Magnetic Resonance Imaging 2000 11 4 343 350 (Pubitemid 30185873)
63. Lecouvet F. E., Geukens D., Stainier A., Jamar F., Jamart J., D'Othée B. J., Therasse P., Vande Berg B., Tombal B., Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies Journal of Clinical Oncology 2007 25 22 3281 3287 (Pubitemid 47325613)
64. Lecouvet F. E., Simon M., Tombal B., Jamart J., Vande Berg B. C., Simoni P., Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa) European Radiology 2010 20 12 2973 2982
65. Luboldt W., Kfer R., Blumstein N., Toussaint T. L., Kluge A., Seemann M. D., Luboldt H. J., Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and11C-choline PET/CT for detection of bone metastases Radiology 2008 249 3 1017 1025
66. Venkitaraman R., Cook G. J. R., Dearnaley D. P., Parker C. C., Khoo V., Eeles R., Huddart R. A., Horwich A., Sohaib S. A., Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer Journal of Medical Imaging and Radiation Oncology 2009 53 3 241 247
67. Kwee T. C., Takahara T., Ochiai R., Nievelstein R. A. J., Luijten P. R., Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology European Radiology 2008 18 9 1937 1952
68. Vilanova J. C., Barceló J., Diffusion-weighted whole-body MR screening European Journal of Radiology 2008 67 3 440 447